EAACI Biologicals Guidelines—Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12–17 years old. 2021 Jul
https://onlinelibrary.wiley.com/doi/full/10.1111/all.15030
Menu
Consensos
Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria: A systematic review for the EAACI Biologicals Guidelines. 2021 Jan;76(1):59-70
https://onlinelibrary.wiley.com/doi/epdf/10.1111/all.14547
The definition, diagnostic testing, and management of chronic inducible urticaria – The EAACI/GA(2) LEN/EDF/UNEV consensus recommendations 2016 update and revision. 2016;71(6):780-802
https://onlinelibrary.wiley.com/doi/epdf/10.1111/all.12884
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. 2018 Jul;73(7):1393-1414
https://onlinelibrary.wiley.com/doi/full/10.1111/all.13397
Guia prático da Associação Brasileira de Alergia e Imunologia para o diagnóstico e tratamento das urticárias baseado em diretrizes internacionais. Arq Asma Alerg Imunol. 2019;3(4):382-392
http://aaai-asbai.org.br/detalhe_artigo.asp?id=1045
Consenso sobre manejo diagnóstico e terapêutico da urticária crônica espontânea do adulto – SBD. Anais Brasileiros de Dermatologia. 2019;94(2) Suppl 1:56-66 https://www.scielo.br/j/abd/a/bcWZgmS7S79Wwzwr7pTw4RG/?lang=en
The International EAACI/GA²LEN/EuroGuiDerm/APAAACI Guideline for the Definition, Classification, Diagnosis and Management of Urticaria. Allergy. 2021 Sep 18.
https://onlinelibrary.wiley.com/doi/10.1111/all.15090